AMG-510 for Lung neoplasm malignant: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 5 adverse event reports in the FDA FAERS database where AMG-510 was used for Lung neoplasm malignant.
Most Reported Side Effects for AMG-510
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Non-small cell lung cancer | 134 | 36.7% | 56 | 22 |
| Hepatic cytolysis | 48 | 13.2% | 1 | 9 |
| Death | 33 | 9.0% | 33 | 3 |
| Diarrhoea | 31 | 8.5% | 3 | 10 |
| Cholestasis | 17 | 4.7% | 0 | 6 |
| Dyspnoea | 9 | 2.5% | 4 | 8 |
| Alanine aminotransferase increased | 8 | 2.2% | 2 | 4 |
| Colitis | 7 | 1.9% | 0 | 7 |
| Dehydration | 7 | 1.9% | 0 | 7 |
| Drug-induced liver injury | 7 | 1.9% | 0 | 5 |
| Respiratory failure | 7 | 1.9% | 7 | 5 |
| General physical health deterioration | 6 | 1.6% | 4 | 0 |
| Hypokalaemia | 6 | 1.6% | 1 | 5 |
| Pulmonary embolism | 6 | 1.6% | 1 | 5 |
| Fatigue | 5 | 1.4% | 0 | 1 |
Other Indications for AMG-510
K-ras gene mutation (173)
Non-small cell lung cancer (160)
Non-small cell lung cancer metastatic (103)
Non-small cell lung cancer stage iv (62)
Lung adenocarcinoma (12)
Other Drugs Used for Lung neoplasm malignant
ERLOTINIB (9,207)
OSIMERTINIB (4,754)
NIVOLUMAB (4,197)
PEMBROLIZUMAB (3,575)
CARBOPLATIN (3,487)
ALECTINIB (2,932)
PEMETREXED (2,422)
CRIZOTINIB (1,949)
BEVACIZUMAB (1,810)
PACLITAXEL (1,747)